1. Home
  2. Epicentre
  3. team
  4. Birgit Schramm
Back to the list
Photo
Birgit Schramm

Birgit Schramm

Titre du poste
Epidemiologist
Contact by mail
Corps éditorial

Biography

Birgit Schramm joined Epicentre as Epidemiologist in 2008. She has a background in Molecular Virology and in Control of Infectious Diseases. The focus of the past years was operational research in various MSF settings, including studies on HIV, Drug resistance Tuberculosis, Malaria, Hepatitis C and Diagnostics test evaluations.

Viral suppression and HIV-1 drug resistance 1 year after pragmatic transitioning to dolutegravir first-line therapy in Malawi: a prospective cohort study.

Journal Reference: The lancet. HIV 2022 Aug ; 9(8); . doi: 10.1016/S2352-3018(22)00136-9. Epub 2022 07 29

High prevalence of NRTI and NNRTI drug resistance among ART-experienced, hospitalized inpatients.

Journal Reference: Journal of acquired immune deficiency syndromes (1999) 2021 Apr 01; . doi: 10.1097/QAI.0000000000002689. Epub 2021 04 01

High level of HIV drug resistance informs dolutegravir roll-out and optimized NRTI backbone strategy in Mozambique.

Journal Reference: JAC-Antimicrobial Resistance, Volume 3, Issue 2, June 2021, dlab050

Potential value of urine lateral-flow lipoarabinomannan (LAM) test for diagnosing tuberculosis among severely acute malnourished children.

Journal Reference: PloS one 2021 ; 16(5); e0250933. doi: 10.1371/journal.pone.0250933. Epub 2021 05 05

MDR M. tuberculosis outbreak clone in Eswatini missed by Xpert has elevated bedaquiline resistance dated to the pre-treatment era.

Journal Reference: Genome medicine 2020 Nov 25; 12(1); 104. doi: 10.1186/s13073-020-00793-8. Epub 2020 11 25

"We give them threatening advice…": expectations of adherence to antiretroviral therapy and their consequences among adolescents living with HIV in rural Malawi.

Journal Reference: Journal of the International AIDS Society 2020 Mar ; 23(3); e25459. doi: 10.1002/jia2.25459. Epub 2020 03 20

Implementation and operational feasibility of SAMBA I HIV-1 semi-quantitative viral load testing at the point of care in rural settings in Malawi and Uganda.

Journal Reference: Tropical medicine & international health : TM & IH 2020 Nov 07; . doi: 10.1111/tmi.13519. Epub 2020 11 07

'I saw it as a second chance': A qualitative exploration of experiences of treatment failure and regimen change among people living with HIV on second- and third-line antiretroviral therapy in Kenya, Malawi and Mozambique.

Journal Reference: Global public health 2019 Jan 11; 1-13. doi: 10.1080/17441692.2018.1561921. Epub 2019 01 11

Point-of-care viral load monitoring: outcomes from a decentralized HIV programme in Malawi.

Journal Reference: Journal of the International AIDS Society 2019 Aug ; 22(8); e25387. doi: 10.1002/jia2.25387. Epub 2019 08 23

HIV-1 drug resistance testing at second-line regimen failure in Arua, Uganda: avoiding unnecessary switch to an empiric third-line.

Journal Reference: Tropical medicine & international health : TM & IH 2018 Oct ; 23(10); 1075-1083. doi: 10.1111/tmi.13131. Epub 2018 10 02

Single low-dose primaquine for blocking transmission of Plasmodium falciparum malaria - a proposed model-derived age-based regimen for sub-Saharan Africa.

Journal Reference: BMC medicine 2018 01 18; 16(1); 11. doi: 10.1186/s12916-017-0990-6. Epub 2018 01 18

Mortality and clinical outcomes in children treated with antiretroviral therapy in four African vertical programmes during the first decade of paediatric HIV care, 2001-2010.

Journal Reference: Tropical medicine & international health : TM & IH 2017 03 ; 22(3); 340-350. doi: 10.1111/tmi.12830. Epub 2017 01 26

Risk factors and mortality associated with resistance to first-line antiretroviral therapy: multicentric cross-sectional and longitudinal analyses.

Journal Reference: Journal of acquired immune deficiency syndromes (1999) 2015 Apr 15; 68(5); 527-35. doi: 10.1097/QAI.0000000000000513. Epub 2015 05 18

Tolerability and safety of artesunate-amodiaquine and artemether-lumefantrine fixed dose combinations for the treatment of uncomplicated Plasmodium falciparum malaria: two open-label, randomized trials in Nimba County, Liberia.

Journal Reference: Malaria journal 2013 Jul 17; 12 250. doi: 10.1186/1475-2875-12-250. Epub 2013 07 17

Efficacy of artesunate-amodiaquine and artemether-lumefantrine fixed-dose combinations for the treatment of uncomplicated Plasmodium falciparum malaria among children aged six to 59 months in Nimba County, Liberia: an open-label randomized non-inferiority trial.

Journal Reference: Malaria journal 2013 Jul 17; 12 251. doi: 10.1186/1475-2875-12-251. Epub 2013 07 17

Field evaluation of a simple fluorescence method for detection of viable Mycobacterium tuberculosis in sputum specimens during treatment follow-up.

Journal Reference: Journal of clinical microbiology 2012 Aug ; 50(8); 2788-90. doi: 10.1128/JCM.01232-12. Epub 2012 05 30

Heterogeneous decrease in malaria prevalence in children over a six-year period in south-western Uganda.

Journal Reference: Malaria journal 2011 May 18; 10 132. doi: 10.1186/1475-2875-10-132. Epub 2011 05 18

Immunovirological outcomes and resistance patterns at 4 years of antiretroviral therapy use in HIV-infected patients in Cambodia.

Journal Reference: Tropical medicine & international health : TM & IH 2011 Feb ; 16(2); 205-13. doi: 10.1111/j.1365-3156.2010.02689.x. Epub 2010 11 19
See all